Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancerMasaki Shiota, Amina Zoubeidi|Oncotarget|2015Cited by 44
Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancerMasaki Shiota, Seiji Naito|Endocrine Related Cancer|2015Cited by 44